山东大学耳鼻喉眼学报 ›› 2019, Vol. 33 ›› Issue (3): 95-99.doi: 10.6040/j.issn.1673-3770.1.2019.015

• 论著 • 上一篇    下一篇

鼻腔鼻窦恶性黑色素瘤23例临床分析

张佳程,张立庆(),周涵,陆美萍,许万云,沈宇杰,刘雅琴,殷敏,董伟达()   

  1. 南京医科大学第一附属医院 江苏省人民医院耳鼻咽喉科,江苏 南京 210029
  • 收稿日期:2019-03-01 修回日期:2019-05-03 出版日期:2019-05-20 发布日期:2019-08-07
  • 通讯作者: 张立庆,董伟达 E-mail:119835289@qq.com;weidadong2649@126.com
  • 基金资助:
    江苏省卫生计生委面上课题(H201603);江苏省青年医学人才项目(QNRC2016614)

Analysis of malignant melanoma of the nasal cavity and paranasal sinuses in 23 cases

Jiacheng ZHANG,Liqing ZHANG(),Han ZHOU,Meiping LU,Wanyun XU,Yujie SHEN,Yaqin LIU,Min YIN,Weida DONG()   

  1. Department of Otorhinolaryngology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China
  • Received:2019-03-01 Revised:2019-05-03 Online:2019-05-20 Published:2019-08-07
  • Contact: Liqing ZHANG,Weida DONG E-mail:119835289@qq.com;weidadong2649@126.com

摘要: 目的

探讨鼻腔鼻窦恶性黑色素瘤的临床特征、诊断、治疗方法及预后,以提高对该病的诊疗水平。

方法

对南京医科大学第一附属医院2007年10 月至 2018年 9月收治的23例鼻腔鼻窦恶性黑色素瘤的临床资料进行回顾性分析。

结果

23例平均61.7岁,男女比例相仿,肿瘤多发生于鼻腔外侧壁,并常累及上颌窦、额窦和筛窦;治疗后随访6个月~10年,1年生存率为78.26%(18/23),2年生存率为42.10%(8/19),3年生存率为20.00%(3/15),5年生存率为11.11%(1/9)。

结论

鼻腔鼻窦恶性黑色素瘤症状隐匿且复杂多变,恶性程度及转移率高,预后差。治疗上提倡广泛的手术切除及术后个体化的化疗、放疗、靶向及生物免疫治疗,早期诊断及综合治疗是提高生存率的关键。

关键词: 黑色素瘤, 鼻腔, 鼻窦, 诊断, 预后, 外科手术, 综合疗法

Abstract: Objective

To explore the clinical features, diagnosis, treatment outcomes, and prognosis of patients with malignant melanoma of the nasal cavity and paranasal sinuses.

Methods

A retrospective review was performed of 23 patients with malignant melanoma of the nasal cavity and paranasal sinuses treated between October 2007 and September 2018.

Results

The average age of the 23 patients was 61.7 years. The proportions of men and women were similar. The tumors mostly occurred in the lateral wall of the nasal cavity and often involved the maxillary, frontal, and ethmoid sinuses. After treatment, the patients were followed-up for 6 months to 10 years. The 1-, 2-, 3-, and 5-year survival rates were 78.26% (18/23), 42.10% (8/19), 20% (3/15), and 11.11% (1/9), respectively.

Conclusion

The symptoms of malignant melanoma of the nasal cavity and sinuses are concealed and complex, with high degrees of malignancy and metastasis and extremely poor prognosis. The treatment strategy includes extensive surgical resection and postoperative individualized chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Early diagnosis and comprehensive treatment can significantly improve the survival rate of malignant melanoma.

Key words: Melanoma, Nasal cavity, Paranasal sinuses, Diagnosis, Prognosis, Surgical procedures, operative, Combined modality therapy

中图分类号: 

  • R765

图1

例1患者临床及病理资料"

图2

例2患者临床及病理资料"

1 KellerDS, ThomayAA, GaughanJ, et al. Outcomes in patients with mucosal melanomas[J]. J Surg Oncol, 2013, 108(8): 516-520. doi:10.1002/jso.23445.
doi: 10.1002/jso.23445
2 GavrielH, McArthurG, SizelandA, et al. Review: mucosal melanoma of the head and neck[J]. Melanoma Res, 2011, 21(4): 257-266. doi:10.1097/cmr.0b013-e328-3470ffd.
doi: 10.1097/cmr.0b013-e328-3470ffd
3 LindsayCR, SpiliopoulouP, WaterstonA. Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer[J]. Ther Adv Med Oncol, 2015, 7(2): 107-121. doi:10.1177/1758834014566619.
doi: 10.1177/1758834014566619
4 MedinaJE, FerlitoA, PellitteriPK, et al. Current management of mucosal melanoma of the head and neck[J]. J Surg Oncol, 2003, 83(2): 116-122. doi:10.1002/jso.10247.
doi: 10.1002/jso.10247
5 BatsakisJG, SuarezP. Mucosal melanomas: a review[J]. Adv Anat Pathol, 2000, 7(3): 167-180.doi:10.1097/00125480-200007030-00006
doi: 10.1097/00125480-200007030-00006
6 ZhuZQ, LiuW, GotliebV. The rapidly evolving therapies for advanced melanoma: towards immunotherapy, molecular targeted therapy, and beyond[J]. Crit Rev Oncol Hematol, 2016, 99: 91-99. doi:10.1016/j.critrevonc. 2015.12.002.
doi: 10.1016/j.critrevonc. 2015.12.002
7 LourençoSV, FernandesJD, HsiehR, et al. Head and neck mucosal melanoma: a review[J]. Am J Dermatopathol, 2014, 36(7): 578-587. doi:10.1097/DAD.00000000-00000035.
doi: 10.1097/DAD.00000000-00000035
8 王梦君. 鼻腔鼻窦恶性黑色素瘤的临床诊疗进展[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 116-120. doi:10.6040/j.issn.1673-3770.0.2016.293.
doi: 10.6040/j.issn.1673-3770.0.2016.293
WANGMengjun. Advances in clinical diagnosis and treatment of sinonasal mucosal malignant melanoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017, 31(2): 116-120. doi:10.6040/j.issn.1673-3770.0.2016.293.
doi: 10.6040/j.issn.1673-3770.0.2016.293
9 BacharG, LohKS, O′SullivanB, et al. Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital[J]. Head Neck, 2008, 30(10): 1325-1331. doi:10.1002/hed.20878.
doi: 10.1002/hed.20878
10 周兵, 王洁, 王晨亮. 原发性鼻腔黏膜恶性黑色素瘤6例临床病理分析并文献复习[J]. 临床与实验病理学杂志, 2015, 31(5): 587-588,589. doi:10.13315/j.cnki.cjcep.2015.05.027.
doi: 10.13315/j.cnki.cjcep.2015.05.027
11 刘雯, 曾智, 周亨, 等. 原发性鼻黏膜恶性黑色素瘤17例临床病理分析[J]. 临床与实验病理学杂志, 2017, 33(2): 169-173. doi:10.13315/j.cnki.cjcep.2017.02.012.
doi: 10.13315/j.cnki.cjcep.2017.02.012
LIUWen, ZENGZhi, ZHOUHeng, et al. Primary mucosal melanoma of the nasal cavity: a linicopathological analysis of 17 cases[J]. Chinese Journal of Clinical and Experimental Pathology, 2017, 33(2): 169-173. doi:10.13315/j.cnki.cjcep.2017.02.012.
doi: 10.13315/j.cnki.cjcep.2017.02.012
12 杨娜, 张佳, 孙克巍. 鼻腔恶性黑色素瘤的确诊及治疗分析[J]. 中国耳鼻咽喉头颈外科, 2016, 23(4): 237-238. doi:10.16066/j.1672-7002.2016.04.014.
doi: 10.16066/j.1672-7002.2016.04.014
13 吴云腾, 任国欣, 孙沫逸, 等. 中国头颈黏膜黑色素瘤临床诊治专家共识[J]. 中国口腔颌面外科杂志, 2015, 13(3): 262-269.
WUYunteng, RENGuoxin, SUNMoyi, et al. Chinese expert consensus document on head and neck mucosal malignant melanoma[J]. China Journal of Oral and Maxillofacial Surgery, 2015, 13(3): 262-269.
14 MatinRN, ChikhA, ChongSL, et al. p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis[J]. J Exp Med, 2013, 210(3): 581-603. doi:10.1084/jem.20121439.
doi: 10.1084/jem.20121439
15 徐婧雯, 蒋惠慈, 陈汐敏, 等. 抗体药物治疗黑色素瘤的现状及进展[J]. 中国药科大学学报, 2014, 45(3): 259-266. doi:10.11665/j.issn.1000-5048.20140302.
doi: 10.11665/j.issn.1000-5048.20140302
XUJingwen, JIANGHuici, CHENXimin, et al. Advances in antibody drugs for treatment of melanoma[J]. Journal of China Pharmaceutical University, 2014, 45(3): 259-266. doi:10.11665/j.issn.1000-5048.20140302.
doi: 10.11665/j.issn.1000-5048.20140302
16 McDermottDF, AtkinsMB. PD-1 as a potential target in cancer therapy[J]. Cancer Med, 2013, 2(5): 662-673. doi:10.1002/cam4.106.
doi: 10.1002/cam4.106
17 SwaikaA, HammondWA, JosephRW. Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy[J]. Mol Immunol, 2015, 67(2 Pt A): 4-17. doi:10.1016/j.molimm.2015.02.009.
doi: 10.1016/j.molimm.2015.02.009
[1] 冯思聪,于晓岚,娄丹. 基于囊泡组织Ki67、GM-CSF表达评估Messerklinger中鼻甲成形术对慢性鼻-鼻窦炎合并鼻息肉的效果[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 31-39.
[2] 翟雪纯,边欣,陈敬彩,邓家钰,叶子,杨萍丽. 慢性额窦炎患者焦虑抑郁特点及横断面研究[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 35-43.
[3] 刘佳珲,田汝宪,李玉梅,宋西成. 构建铜死亡相关lncRNA模型评估头颈鳞状细胞癌预后[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 49-64.
[4] 唐嘉骏,后婕,窦鑫,俞晨杰. 鼻腔框架结构畸形影响鼻腔结构及鼻窦气化的CT研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 102-110.
[5] 朱江,刘太祥,江兵. 经鼻内镜下泪囊鼻腔吻合手术前后结膜囊菌群变化[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 13-20.
[6] 缪红利,张妍春,郝琳娜,唐乐,何英楠. 活动性眼弓形虫病临床特征及预后分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 82-89.
[7] 卢朝阳, 翟兆雪, 王慧康, 邵丽婷, 张宇. 新冠肺炎治疗引发糖尿病酮症酸中毒合并鼻眶脑型毛霉菌病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 90-94.
[8] 彭中华,陈竹,袁洛花,余绍兰,马玉玲. 原发性鼻腔高级别非肠型腺癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 95-98.
[9] 程卓, 梁辉, 邢鲁民. 深度学习技术在咽喉内镜应用中的研究进展及前景分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 112-119.
[10] 刘一洁,卢秀珍,吴秋欣. 外泌体在眼病发病机制和诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 135-141.
[11] 李赞,卢奇,申卫东,侯昭晖,吴南. 坏死性外耳道炎临床诊治18例[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 17-22.
[12] 马孝宝,沈佳丽,杨军,陈建勇,朱颂欢. 水平半规管扫视波的临床意义探究[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 40-45.
[13] 李阳松,袁发洋,杨艳,张田,喻国冻. 基于Web of Science进行生物制剂治疗慢性鼻窦炎文献计量学分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 54-64.
[14] 杜康丽,郑振宇,徐战将,张宇,陈露,卢梦垚. 鼻中隔偏曲并发慢性鼻窦炎风险预测模型的构建与验证[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 78-86.
[15] 刘梓琪,黄佳丽,汪李琴,陈曦,张立庆,周涵. 窄带成像内镜联合嗓音声学分析在声带白斑鉴别诊断中的价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 87-96.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!